References
Neumann-Jensen B, Worsaae N, Dabelsteen E, Ullman S (1980) Pemphigus vulgaris and pemphigus foliaceus coexisting with oral lichen planus. Br J Dermatol 102:585–590
Lee CW, Hur H, Youn JI (1987) Pemphigus vulgaris coexisting with generalized lichen planus. J Dermatol 14:388–391
Vahide L, Zahra H, Forugh G, Nazi S (2017) Autoantibodies to desmogleins 1 and 3 in patients with lichen planus. Arch Dermatol Res 309:579–583. https://doi.org/10.1007/s00403-017-1756-x
Schmidt T, Solimani F, Pollmann R, Stein R, Schmidt A, Stulberg I, Kuhn K, Eming R, Eubel V, Kind P, Arweiler N, Sitaru C, Hertl M (2018) TH1/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus. J Allergy Clin Immunol 142:669–672.e7. https://doi.org/10.1016/j.jaci.2018.02.044
Tavakolpour S, Mahmoudi H, Balighi K, Abedini R, Daneshpazhooh M (2018) Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: a systematic review. Int Immunopharmacol 54:131–138. https://doi.org/10.1016/j.intimp.2017.11.005
Heelan K, McAleer MA, Roche L, McCreary C, Murphy M (2015) Intractable erosive lichen planus treated successfully with rituximab. Br J Dermatol 172:538–540. https://doi.org/10.1111/bjd.13537
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Balighi, K., Mahmoudi, H., Tavakolpour, S. et al. Coexistence of oral lichen planus and pemphigus vulgaris. Clin Oral Invest 22, 2953–2955 (2018). https://doi.org/10.1007/s00784-018-2619-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-018-2619-3